Member Exclusive News

The week in industry: Collaboration to tackle antimicrobial resistance

This week: The US FDA accepts an NDA for treatment of Parkinson’s disease during OFF periods, Australian Therapeutic Goods Administration tightens regulations on stem cell treatments and Clover Health (CA, USA) to launch new subsidiary to develop treatments for chronic diseases

Go to the profile of RxNet
Jul 11, 2019
0
0

Please sign in or register for FREE

No comments yet.